drug development
Drugs OKed Faster in U.S. Than in Europe
Drugs OKed Faster in U.S. Than in Europe
Kerry Grens | Apr 10, 2017
In recent years, the US Food and Drug Administration has approved more drugs and in less time than the European Medicines Agency.
Evaluating Epigenome-Targeting Cancer Therapies
Evaluating Epigenome-Targeting Cancer Therapies
Jef Akst | Apr 3, 2017
At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.
Experimental MERS Treatments Target Host Cell Receptor
Experimental MERS Treatments Target Host Cell Receptor
Ashley Yeager | Mar 30, 2017
Researchers are searching for ways to prevent the coronavirus from attaching to DPP-4 receptors, blocking it from invading and replicating within host cells.
Tetracycline Inventor Dies
Tetracycline Inventor Dies
Kerry Grens | Mar 15, 2017
Lloyd Conover, a longtime chemist at Pfizer, pioneered the concept of chemically altering natural antibiotics to create new drugs.
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
John D. Loike and Jennifer Miller | Feb 1, 2017
What can be done to lower development costs and drug prices?
Infographic: The Cost of Drug Development
Infographic: The Cost of Drug Development
John D. Loike and Jennifer Miller | Feb 1, 2017
Expensive clinical trials and few drug approvals can drive up drug prices for consumers.
Pitcher Plant Enzymes Digest Gluten in Mouse Model
Pitcher Plant Enzymes Digest Gluten in Mouse Model
Jenny Rood | Feb 1, 2017
A newly discovered protease could break down grain proteins that trigger celiac disease.
Califf Vacates FDA’s Top Post
Califf Vacates FDA’s Top Post
Bob Grant | Jan 20, 2017
Robert Califf steps down as FDA Commissioner as Donald Trump takes office.
Drug Approval Timeline Same as 20 Years Ago
Drug Approval Timeline Same as 20 Years Ago
Kerry Grens | Jan 9, 2017
A report finds that new medications still take about 12 years to go from patent to patient.
Repurposing Existing Drugs for New Indications
Repurposing Existing Drugs for New Indications
Anna Azvolinsky | Jan 1, 2017
An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.